Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Cancer Discovery|September 25, 2016
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic DiseaseJing Liu, Stephen J Blake, Michelle C R Yong, et al.
Cancer Discovery|September 19, 2019
Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23Maya Kansara, Kristian Thomson, Puiyi Pang, et al.
Cancer Cell|September 14, 2016
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune ResponsesArabella Young, Shin Foong Ngiow, Deborah S Barkauskas, et al.
European Journal of Neurology|April 5, 2013
Clinico-genetic comparisons of paroxysmal kinesigenic dyskinesia patients with and without PRRT2 mutationsL C S Tan, K Methawasin, E W L Teng, et al.
Cancer Gene Therapy|April 3, 2004
A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cellsMaria Moeller, Nicole M Haynes, Joseph A Trapani, et al.
Cancer Immunology Research|January 30, 2020
Control of Metastases via Myeloid CD39 and NK Cell Effector FunctionJuming Yan, Xian-Yang Li, Amelia Roman Aguilera, et al.
Blood|July 21, 2005
Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejectionMaria Moeller, Nicole M Haynes, Michael H Kershaw, et al.
Cancer Research|August 3, 2007
Combined natural killer T-cell based immunotherapy eradicates established tumors in miceMichele W L Teng, Jennifer A Westwood, Phillip K Darcy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Gene-engineered T cells as a superior adjuvant therapy for metastatic cancerMichael H Kershaw, Jacob T Jackson, Nicole M Haynes, et al.
Cancer Discovery|December 13, 2019
MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1Juming Yan, Stacey Allen, Elizabeth McDonald, et al.
Pageof 11